Xponance, Inc. Horizon Therapeutics Public LTD CO Transaction History

Xponance, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$98.98 - $115.74 $44,442 - $51,967	449 Added 1.57%	29,120 $3.37 Million
Q2 2023 Jul 13, 2023	SELL	$96.34 - $112.38 $8,285 - $9,664	-86 Reduced 0.3%	28,671 $2.95 Million
Q1 2023 Apr 17, 2023	BUY	$107.32 - $113.5 $18,351 - $19,408	171 Added 0.6%	28,757 $3.14 Million
Q4 2022 Jan 23, 2023	BUY	$62.39 - $113.8 $223,855 - $408,314	3,588 Added 14.35%	28,586 $0
Q3 2022 Oct 24, 2022	BUY	$58.92 - $84.67 $9,427 - $13,547	160 Added 0.64%	24,998 $1.55 Million

Q2 2022 Aug 02, 2022	BUY	$79.4 - $116.36 $1.44 Million - $2.11 Million	18,124 Added 269.94%	24,838 $1.98 Million
Q1 2022 Apr 20, 2022	BUY	$86.42 - $109.81 $15,123 - $19,216	175 Added 2.68%	6,714 $706,000
Q4 2021 Jan 31, 2022	SELL	$98.56 - $119.91 $3,942 - $4,796	-40 Reduced 0.61%	6,539 $705,000
Q3 2021 Nov 05, 2021	SELL	$91.91 - $110.37 $74,355 - $89,289	-809 Reduced 10.95%	6,579 $721,000
Q2 2021 Aug 12, 2021	SELL	$86.24 - $95.92 $999,090 - $1.11 Million	-11,585 Reduced 61.06%	7,388 $692,000
Q1 2021 May 10, 2021	BUY	$71.83 - $95.48 $17,023 - $22,628	237 Added 1.26%	18,973 $1.75 Million
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $18,492 - $23,291	-276 Reduced 1.45%	18,736 $1.37 Million
Q3 2020 Oct 26, 2020	BUY	$55.23 - $79.93 $74,726 - $108,145	1,353 Added 7.66%	19,012 $1.48 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $533,301 - $1.01 Million	17,659 New	17,659 $981,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.